Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
Conditions
- BCLC Stage B Hepatocellular Carcinoma
- BCLC Stage C Hepatocellular Carcinoma
- Hepatitis C Infection
- Refractory Liver Carcinoma
- Stage III Hepatocellular Carcinoma AJCC v7
- Stage IIIA Hepatocellular Carcinoma AJCC v7
- Stage IIIB Hepatocellular Carcinoma AJCC v7
- Stage IIIC Hepatocellular Carcinoma AJCC v7
- Stage IV Hepatocellular Carcinoma AJCC v7
- Stage IVA Hepatocellular Carcinoma AJCC v7
- Stage IVB Hepatocellular Carcinoma AJCC v7
Interventions
- DRUG: Elbasvir/Grazoprevir
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pembrolizumab
- DRUG: Ribavirin
Sponsor
M.D. Anderson Cancer Center
Collaborators